Author: Ravi Shankar

VANCOUVER, British Columbia, Oct. 22, 2026 (GLOBE NEWSWIRE) — Precore Gold Corp. (CSE: PRCG) (the “Company” or “Precore Gold”) is pleased to announce the appointment of Andrew Disipio to its Board of Directors and Christina Lalli as Vice President, Investor Relations to its management team.

Paul A. Dumas, Executive Chairman of Precore Gold, commented: “Andrew’s mining-industry knowledge, capital-markets expertise and experience with some of the sector’s most consequential transactions will be invaluable as we advance our exploration strategy and evaluate opportunities to create long-term shareholder value. Christina brings deep mining-sector experience and long-standing relationships across the Canadian, U.S. and European investment communities, and knows how to translate technical progress into a clear capital-markets story. Her experience will be instrumental in broadening Precore’s market presence and strengthening shareholder engagement.”

Andrew Disipio (Joining as Director)

Mr. Disipio is a Partner at Bennett Jones LLP, one of Canada’s leading business law firms, where he serves as Head of its National Mining Practice, with a focus on M&A and capital markets transactions. Mr. Disipio is ranked in Chambers Global (International & Cross-Border) and Chambers Canada for Mining and in Lexpert for Corporate Finance & Securities and Mining. He was named a Lexpert Rising Star (Top 40 under 40) in 2025 and featured in the 2026 Lexpert Special Edition lists for Mining and Finance & M&A.

Throughout his career, Mr. Disipio has advised mining companies at every stage of their development: from formation and exploration through project development, production and strategic consolidation, having led some of the most high-profile M&A transactions in the Canadian mining industry.

Mr. Disipio holds a Master of Laws from Osgoode Hall Law School, a Juris Doctor (Cum Laude) from the University of Pittsburgh School of Law and a Bachelor of Commerce (Honours) from Queen’s University. He is called to the bar in Ontario and New York.

Mr. Disipio commented: “I am delighted to join Precore’s Board at such an exciting stage in the Company’s development. Having advised mining companies through every stage of growth, I see real potential in Precore’s portfolio and its disciplined approach to exploration. I look forward to working with the Board and management to strengthen the Company’s governance, support its capital-markets strategy and help position Precore to create long-term value for shareholders.”

Christina Lalli (Joining as VP Investor Relations)

Ms. Lalli is a capital-markets and investor-relations executive with more than 20 years of experience, principally in the mining sector, and an extensive network of institutional investors, dealers, analysts and resource-focused investors across Canada, the United States and Europe.

Most recently, she was Vice President, Investor Relations of TRX Gold Corporation during a transformative period for its Buckreef Gold operation in Tanzania. She previously held senior investor-relations roles with Osisko Metals Incorporated and Nouveau Monde Graphite Inc. and, earlier in her career, with the original Osisko Mining Corporation. Her experience spans precious metals, base metals and critical minerals, and companies ranging from early-stage explorers to emerging producers.

Ms. Lalli commented: “I am very pleased to join Precore Gold at an exciting stage in its development. With two highly prospective projects, an experienced team and a tightly held capital structure, Precore is a compelling junior exploration opportunity. I look forward to expanding the Company’s visibility within the global mining-investment community and keeping shareholders informed as Precore advances its exploration objectives.”

Ms. Lalli holds a Bachelor of Arts from Concordia University and a Graduate Diploma in Human Resources Management from McGill University, is a graduate of the Ivey School of Business Investor Relations program, holds the Certified Professional in Investor Relations designation and is a member of the Canadian Investor Relations Institute.

About Precore Gold Corp.

Precore Gold is a Canadian junior gold exploration company focused on building a solid portfolio of exploration projects with strong gold discovery potential, in order to capture the strength of the gold market and to generate long-term shareholder returns. The Company is focused on its flagship properties, the Arikepay property in Arequipa, Peru and the Lac Big-Rush property in Chibougamau, Quebec. The Company plans to seize opportunities whereby promising properties are located in prolific mining camps, in politically stable jurisdictions, that contain important historical drilling results that have not seen any follow-up work in years. Precore Gold’s mission is underpinned by diligent environmental, social and corporate governance (ESG) standards.

For shareholder inquiries, please contact:

Paul A. Dumas, Executive Chairman
Email: investor@precoregold.com
Tel: 514-994-1069
www.precoregold.com

Forward-looking statements

This news release contains forward-looking statements. All statements, other than of historical facts, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future including, without limitation, the completion of the Second Tranche, future geological work or exploration programs, the potential positive exploration results, the timing of the exploration results, the ability of the Company to finance exploration programs and the potential mineralization or potential mineral resources are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “to earn”, “to have’, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, failure to meet expected, estimated or planned exploration expenditures, failure to establish estimated mineral resources, the possibility that future exploration results will not be consistent with the Company’s expectations, general business and economic conditions, changes in world gold markets, sufficient labour and equipment being available, changes in laws and permitting requirements, unanticipated weather changes, title disputes and claims, environmental risks as well as those risks identified in the Company’s annual Management’s Discussion and Analysis. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described and accordingly, readers should not place undue reliance on forward-looking statements. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update these forward-looking statements except as otherwise required by applicable law.

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

HONG KONG, Oct. 22, 2026 (GLOBE NEWSWIRE) — 3 E Network Technology Group Limited (Nasdaq: MASK) (the “Company” or “3 E Network”), a business-to-business (“B2B”) information technology (“IT”) business solutions provider committed to becoming a next-generation artificial intelligence (“AI”) infrastructure solutions provider, today announced that its wholly-owned subsidiary, 3e Network Technology Company Limited (HK), has begun shipping the first batch of products under its recently announced approximately $5.0 million core storage hardware sales contract.

Initial Core Storage Components Shipped

This phased delivery primarily involves large quantities of enterprise-grade high-density memory modules and data center-grade storage controllers. Supported by the Company’s global logistics network, the initial components have been successfully dispatched, with subsequent batches scheduled for delivery over the coming quarters based on a mutually agreed timeline.

The on-time dispatch of this first batch marks a milestone in fulfilling the agreement and progressing toward revenue recognition, while also demonstrating 3 E Network’s coordination capabilities in large-scale hardware procurement and cross-border order fulfillment. It marks the transition from contract signing to delivery.

Providing Pre-Shipment System-Level Verification to Mitigate Integration Risks

In addition to standard hardware delivery, 3 E Network has also provided technical support for this order. Prior to shipment, the Company’s technical team conducted system-level compatibility and interoperability verification on the storage equipment. By conducting these pre-shipment verification procedures, the Company helps end clients mitigate the system integration risks that can arise when incorporating independent hardware into existing data center architectures. This helps meet the client’s technical operating standards and provides the Company with engineering and operational experience for undertaking more complex integrated hardware and software procurement projects for compute centers in the future.

Phased Delivery Supports Revenue Recognition and Internal Funding

As the delivery process advances, the corresponding sales revenue is expected to be recognized progressively based on fulfillment milestones, with related customer payments contributing to operating cash flow. This phased delivery and collection model is expected to improve the Company’s revenue visibility over the next few quarters while providing additional working capital.

The non-dilutive cash flow generated from this business will be directly allocated to support the Company’s ongoing capital-intensive and advanced technology projects. This includes the Mikkeli 9 MVA AI compute center in Finland, currently in the hardware Request for Proposal (RFP) evaluation phase, and the microarchitecture R&D for the next-generation proprietary AI Storage Controller. This approach reflects the Company’s strategy of using its core hardware and solutions business to support its advanced infrastructure initiatives.

Management Commentary

Dr. Tingjun Yang, Chief Executive Officer of 3 E Network, stated, “The on-schedule dispatch of the initial storage components signifies that this approximately $5.0 million contract has transitioned from a signed agreement into tangible fulfillment. Our team managed the process, from staging and testing to shipment, within the established timeframe, demonstrating the Company’s operational execution when handling enterprise-level high-volume hardware demands.”

Dr. Yang added, “As this order enters a regular delivery and payment cycle, we expect the related revenue to be progressively reflected in our financial statements. The management team will continue to take a pragmatic approach, using operating cash flow generated by our enterprise IT solutions business to support the construction of our European AI compute center and the R&D of our proprietary AI chip. Our objective is to maintain the stable operation of our core IT business while taking steady and methodical steps to expand our long-term competitive edge in the AI compute infrastructure market.”

About 3 E Network Technology Group Limited
3 E Network Technology Group Limited is a business-to-business (“B2B”) information technology (“IT”) business solutions provider committed to becoming a next-generation artificial intelligence (“AI”) infrastructure solutions provider. It upholds the industry consensus of “AI and energy symbiosis” and has a strong vision in the field of energy investment. The Company’s business comprises two main portfolios: the data center operation services portfolio and the software development portfolio. For more information, please visit the Company’s website at https://3emask.com/.

Forward-Looking Statements
Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Investors can identify these forward-looking statements by words or phrases such as “approximates,” “assesses,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect the Company’s future results in the Company’s registration statement and other filings with the U.S. Securities and Exchange Commission.

For more information, please contact:

3 E Network Technology Group Limited
Investor Relations Department
Email: ird@3emask.com
Website: https://3emask.com/

Fusion Fuel to Issue 500,000 Class A Ordinary Shares at an Agreed Value of $4.00 Per Share in Exchange for $2.0 Million of QIND Equity

Restructuring Expected to Reduce QIND’s Remaining Al Shola Gas Purchase Price Obligations by $2.0 Million to Approximately $7.0 Million and Removes Legacy Financing Commitments

Al Shola Gas to Make Quarterly Dividend Distributions Commencing from the Third Quarter of 2026

Dublin, Ireland, Oct. 22, 2026 (GLOBE NEWSWIRE) — Fusion Fuel Green PLC (Nasdaq: HTOO) (“Fusion Fuel” or the “Company”), a diversified energy platform, today announced that it has entered into a Share Exchange Agreement, dated as of September 23, 2026 (the “Share Exchange Agreement”), with its majority-owned subsidiary, Quality Industrial Corp. (OTCID: QIND) (“QIND”), in connection with the restructuring of QIND’s remaining purchase price obligations for its 51% ownership interest in Al Shola Al Modea Gas Distribution L.L.C. (“Al Shola Gas”). Concurrently, QIND, Al Shola Gas and the three individual shareholders of Al Shola Gas, who collectively own the remaining 49% of Al Shola Gas (the “ASG Shareholders”), entered into an Agreement and Amendment No. 2 to the Share Purchase Agreement, dated as of September 23, 2026 (the “Amendment”), which amends the Share Purchase Agreement dated March 27, 2024, as amended by the Amendment Agreement dated April 8, 2025, to restructure the remaining purchase price and related obligations.

Under the Share Exchange Agreement, subject to the satisfaction of closing conditions, the Company will issue to the ASG Shareholders an aggregate of 500,000 Class A Ordinary Shares of Fusion Fuel (calculated by dividing $2.0 million by an agreed price of $4.00 per share, subject to adjustment for any share consolidation, share split, share dividend or similar event), allocated 40% to Sanjeeb Safir, 40% to Safir Ahammed and 20% to Mohamed Hilal Saeed Muroushad Almheiri. Under the Amendment, the issuance of these shares is expected to satisfy $2.0 million of QIND’s remaining purchase price obligations to the ASG Shareholders; that portion of the purchase price will not be deemed paid unless and until the shares are actually issued or the Alternative Payment described below is made. As consideration for the issuance of the Fusion Fuel shares, QIND will issue to the Company shares of QIND common stock with an aggregate value of $2.0 million, with the number of shares determined by dividing $2.0 million by the lower of (i) the closing price of QIND’s common stock immediately preceding the closing date and (ii) the average closing price of QIND’s common stock for the five trading days ending on the trading day immediately preceding the closing date.

The total purchase price for QIND’s 51% interest in Al Shola Gas remains $10.0 million. Of this amount, $1.02 million has previously been paid in cash and $2.0 million is to be satisfied through the issuance of the Fusion Fuel shares. The remaining $6.98 million is payable on or before December 31, 2027, comprising $6.0 million payable in any form determined by QIND in its sole discretion, including cash or securities that are listed on a securities exchange at the time of delivery, and $980,000 payable in cash. QIND’s obligation to make the remaining purchase price payments is conditioned upon the ASG Shareholders having complied in all material respects with their cooperation obligations in connection with the closing of the Share Exchange Agreement and upon either such closing or QIND’s payment of the Alternative Payment. The Amendment also eliminates QIND’s previously existing obligations to provide or arrange debt financing, credit facilities, equity lines or bank guarantees for the benefit of Al Shola Gas or the ASG Shareholders, replaces the prior working capital provisions with an obligation of QIND to use commercially reasonable efforts to facilitate the purchase by Al Shola Gas of one additional LPG bobtail vehicle with approximately 18,000-liter capacity on or before December 31, 2026, with no obligation of QIND to provide or arrange financing for such purchase, and contains a mutual waiver and release of claims, including with respect to any actual or alleged defaults under the prior agreements.

In addition, the Amendment provides that Al Shola Gas will make quarterly dividend distributions equal in aggregate to its profits (as defined in the Amendment) for the previous fiscal quarter, distributed pro rata in accordance with its shareholders’ respective equity interests, commencing from the third quarter of 2026, unless otherwise determined by the Al Shola Gas Board of Directors. The Amendment also grants QIND a right of first refusal over any proposed transfer of Al Shola Gas shares by an ASG Shareholder to a third party, grants QIND an irrevocable option, exercisable on or prior to March 27, 2027, to purchase all or any portion of the ASG Shareholders’ Al Shola Gas shares at $65,359.48 per share, and extends the ASG Shareholders’ non-competition and non-solicitation restrictions from two years to four years.

The Fusion Fuel shares to be issued to the ASG Shareholders will be subject to a six-month lock-up from the date of issuance, during which they may not be sold or otherwise transferred without QIND’s prior written consent, followed by a leak-out restriction limiting each ASG Shareholder’s sales on any trading day to 3% of the total daily trading volume. The Fusion Fuel shares will not be registered under the Securities Act of 1933, as amended, and will be restricted securities. The Company has agreed to file a registration statement on Form F-3 (or other available form) covering the resale of the shares no later than 30 calendar days following the closing date and to use commercially reasonable efforts to cause it to be declared effective no later than 90 calendar days following the closing date; the filing or effectiveness of the registration statement will not affect the lock-up and leak-out restrictions.

The closing under the Share Exchange Agreement is subject to the satisfaction or, where permissible, waiver of a number of conditions set forth in the Share Exchange Agreement, including approval by The Nasdaq Stock Market LLC (“Nasdaq”) of an initial listing application in connection with the transactions, receipt of all required governmental approvals (including any required Nasdaq approvals and any approvals required under the Irish Takeover Panel Act 1997, Takeover Rules), and delivery of accredited investor questionnaires and AML/KYC documentation for each ASG Shareholder. The Share Exchange Agreement does not require the Company to submit, pursue, maintain or seek clearance of any initial listing application with Nasdaq unless and until the Company determines, in its sole discretion, that it will meet the applicable Nasdaq listing requirements at the time of such submission. If the Fusion Fuel shares have not been issued on or before December 31, 2026 because the closing under the Share Exchange Agreement has not occurred, QIND will be required, within ten calendar days thereafter, to satisfy the $2.0 million portion of the purchase price by paying cash or delivering certain other securities in accordance with the Amendment (the “Alternative Payment”). Each of the ASG Shareholders is an individual shareholder of Al Shola Gas, and Mr. Safir is Chief Operating Officer and Managing Director Middle East of QIND. The transactions were approved by the Company’s Board of Directors following review and approval by its Audit Committee.

The restructuring comes as Al Shola Gas continues to expand its operations and recurring revenue base, including the recent addition of a new bobtail delivery vehicle to its LPG distribution fleet in the UAE.

Frederico Figueira de Chaves, Chief Executive Officer of Fusion Fuel, commented, “We believe this transaction represents an attractive and efficient use of our equity while further aligning Fusion Fuel and QIND as we advance our broader strategy. Upon closing, the settlement of $2.0 million of QIND’s remaining purchase price obligations with Fusion Fuel shares at an agreed value of $4.00 per share is expected to reduce QIND’s remaining purchase price obligations to the Al Shola Gas shareholders to approximately $7.0 million, and we believe the lock-up and leak-out structure aligns the Al Shola Gas shareholders with Fusion Fuel’s long-term performance. At the same time, upon closing Fusion Fuel is expected to receive $2.0 million of QIND equity, and we believe the introduction of quarterly dividend distributions creates a clearer path for the cash generated by Al Shola Gas to flow through the group.

“Together with the removal of legacy financing commitments, we believe this strengthens the overall strategic and financial foundation of the business as we work to create value across the broader Fusion Fuel platform.”

About Fusion Fuel Green PLC

Fusion Fuel Green PLC (Nasdaq: HTOO) is a diversified energy platform offering a comprehensive suite of energy supply, distribution, and engineering and advisory solutions through its operating businesses Al Shola Gas, Bright Hydrogen Solutions Ltd (“BrightHy Solutions”) and Biosteam Energy (Proprietary) Limited (“BioSteam Energy”). Al Shola Gas provides full-service industrial LPG solutions, including the design, supply, and maintenance of LPG systems, as well as the transport and distribution of LPG across commercial, industrial, and residential sectors. BrightHy Solutions, the Company’s hydrogen solutions platform, delivers engineering and advisory services enabling decarbonization across hard-to-abate industries. BioSteam Energy provides biomass-powered industrial steam solutions to clients. Through Royal Uranium Inc., the Company also holds a portfolio of uranium and natural gas royalty and other interests across Canada, Colombia and Argentina. For more information, please visit www.fusion-fuel.eu.

About Quality Industrial Corp.

Quality Industrial Corp. is an industrial energy company specializing in LPG infrastructure and distribution. Through its majority-owned subsidiary, Al Shola Gas, QIND provides consulting, engineering, installation, maintenance, and LPG supply services to residential, commercial, and industrial customers across the United Arab Emirates (“UAE”).

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events or the Company’s future financial or operating performance and can be identified by words such as “may,” “will,” “believes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “should,” “seeks,” “future,” “continue,” “plan,” “target,” “predict,” “potential,” or the negative of such terms, or other comparable terminology. Forward-looking statements in this press release include, but are not limited to, statements regarding: the anticipated issuance of 500,000 Fusion Fuel Class A Ordinary Shares to the ASG Shareholders and of QIND common stock to the Company, and the timing of the closing under the Share Exchange Agreement; the satisfaction of the closing conditions under the Share Exchange Agreement; the expected reduction of QIND’s remaining purchase price obligations; the payment of the remaining purchase price on or before December 31, 2027 and any Alternative Payment; the anticipated quarterly dividend distributions by Al Shola Gas; QIND’s facilitation of the purchase of an additional LPG bobtail vehicle by Al Shola Gas; the anticipated filing and effectiveness of a resale registration statement; and the expected benefits of the transactions to the Company and QIND, including the alignment of the ASG Shareholders with the Company’s long-term performance, the flow of cash generated by Al Shola Gas through the Company; and the strengthening of the strategic and financial foundation of the Company’s business. These forward-looking statements are based on current expectations and assumptions and are not guarantees of future performance or results. They involve known and unknown risks, uncertainties, and other important factors, many of which are outside the Company’s control, that could cause actual results to differ materially from those expressed or implied, including, without limitation: the risk that the closing conditions under the Share Exchange Agreement, including Nasdaq approval of an initial listing application (which the Company is not required to submit unless it determines that it will meet the applicable Nasdaq listing requirements) and any approvals required under the Irish Takeover Panel Act 1997, Takeover Rules, are not satisfied in a timely manner or at all; the risk that QIND is unable to issue the required number of shares of its common stock at closing; the material uncertainty regarding the Company’s ability to continue as a going concern, including the Company’s dependence on external financing; QIND’s matured and unpaid convertible notes and the risk of failing to meet payment obligations under the Share Purchase Agreement, dated as of March 27, 2024, relating to Al Shola Gas, as amended, including the Alternative Payment if the closing under the Share Exchange Agreement does not occur by December 31, 2026; the risk that Al Shola Gas does not generate profits sufficient to support dividend distributions, or that its Board of Directors determines not to make such distributions; the risk that Al Shola Gas does not complete the purchase of an additional LPG bobtail vehicle; the risk that the resale registration statement is not filed or declared effective within the required timeframes; the effect of the issuance of the Class A Ordinary Shares on the Company’s existing shareholders and share price; geopolitical instability or armed conflict in the Middle East, including disruptions to shipping through the Strait of Hormuz and the departure of customers from the region, that could disrupt Al Shola Gas’s operations, sales volumes, supply chain and costs in the UAE; fluctuations in LPG and other energy commodity prices; foreign currency fluctuations; and the risks and uncertainties described in Exhibit 99.2 to the Report on Form 6-K/A furnished by the Company with the U.S. Securities and Exchange Commission (the “SEC”) on July 29, 2026, in the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2025, as amended, and in the Company’s other filings with the SEC. Actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. All forward-looking statements in this press release are qualified in their entirety by the cautionary statements above. The Company does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances that may arise after the date hereof, except as required by law.

Investor Relations Contact:
ir@fusion-fuel.eu
www.fusion-fuel.eu

Planned integration of automated LiDAR point cloud classification and feature extraction across ZenaTech’s Drone as a Service locations is designed to cut survey post-processing time and support scalable, recurring revenue

VANCOUVER, British Columbia, Oct. 22, 2026 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech” or the “Company”), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, today unveiled its proprietary artificial intelligence software suite and planed integration across its DaaS land survey operations. By pairing ZenaDrone high-density LiDAR (Light Detection and Ranging) data acquisition with the automated feature extraction and point cloud classification, ZenaTech plans to accelerate survey-grade data delivery time from days to as little as minutes across commercial land surveying, municipal and infrastructure projects for DaaS clients across North America and around the world. The combined platform is currently in the development and testing stage.

“Land survey delivery has traditionally been limited by manual post-processing, which caps how many projects a survey team can complete,” said Shaun Passley, Ph.D., CEO of ZenaTech. “By integrating our AI software directly into ZenaDrone DaaS operations, we aim to automate the heavily manual work of point cloud classification and CAD linework generation, so the same crews and drones can deliver turn-key, actionable intelligence to clients faster and with consistent quality. As we apply our AI suite across our AI tools growing network of DaaS subsidiaries, we believe it can improve operating efficiency and support the scalable, recurring revenue model at the center of our DaaS strategy.”

The combined platform is designed to bridge hardware data collection with AI-driven point cloud processing. A ZenaDrone land survey drone equipped with high-density LiDAR captures a site as a point cloud, a dataset that can contain billions of individual 3D measurement points. ZenaAI is then intended to run automated geospatial workflows on that data, classifying each point by what it represents, converting the classified data into terrain models and vector drawings, removing noise, tagging infrastructure assets and exporting the results in formats that survey and engineering teams can use directly. Its key planned capabilities include:

• Automated Point Cloud Classification: Designed to use deep learning neural networks to rapidly parse billions of 3D LiDAR points, separating ground returns from dense canopy, buildings, utility lines and surface vegetation to generate true Digital Terrain Models (DTM)
• Automated Feature Extraction and Linework: Computer vision algorithms are intended to detect and vectorize critical planimetric features, including curb lines, pavement edges, retaining walls and structures, and export them directly into CAD and BIM (Building Information Modeling) formats
• Rapid DaaS Turnaround: By replacing manual point-picking and heuristic scripting, the AI software suite is being designed to reduce post-processing workflows by as much as 80% and shorten survey turnaround time, allowing DaaS survey teams to deliver fully classified datasets within hours of flight completion
• Smart Noise Filtering and Asset Tagging: Automated artifact suppression is intended to clean airborne noise, multipath errors and scan overlap, while semantic tagging logs discrete infrastructure assets, such as manholes, hydrants and utility poles, with millimeter-level precision

Point cloud classification and linework have traditionally required skilled technicians to work through by hand, which can take days and limits how many projects a survey team can complete. ZenaTech believes that automating these steps could raise surveying productivity, allowing the same drones and crews to deliver more projects faster and potentially improving margins over time. As proprietary software, the AI suite is also intended to add a scalable SaaS layer to the Company’s acquisition-led DaaS strategy, applying a consistent processing workflow across the surveying businesses it acquires and supporting its recurring revenue model for commercial, municipal and infrastructure clients that rely on timely data for planning, design and construction.

The AI-powered LiDAR processing is currently in development with testing across DaaS land surveying, infrastructure monitoring and utility inspection projects expected next year. The Company will provide updates on launch and rollout as milestones are achieved.

ZenaTech’s Drone as a Service (DaaS) division provides on-demand turnkey drone piloting, data capture, and data processing services to commercial, government, and infrastructure customers, allowing them to access aerial data and automation without owning or operating their own drone fleets. The division is being built through an acquisition-led strategy that combines local low-tech service providers into a global network, creating a scalable platform for delivering recurring revenue aerial and data services such as surveying, inspections, power washing and construction progress monitoring.

About ZenaTech

ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) is a technology company that specializes in AI autonomy drone platforms to transform commercial, government, and defense sectors. Its subsidiaries include drone manufacturing through ZenaDrone, a global Drone as a Service (DaaS) business, and an enterprise SaaS division of software brands. The Company is executing an acquisition-led DaaS roll-up strategy to digitize and automate legacy service industries like land surveys and inspections, driving drone-based scalable, recurring revenue growth. With an operating footprint spanning North America, Europe, the Middle East, Asia, and Australia, ZenaTech is advancing AI drones for applications such as agriculture and logistics, as well as ISR, cargo, and counter-UAS for U.S. defense and NATO allies. The company is investing in next-generation technologies, including drone swarms, quantum computing, and advanced AI autonomy to capture long-term opportunities in key markets through its R&D initiatives.

About ZenaDrone

ZenaDrone, a subsidiary of ZenaTech, develops and manufactures AI-powered multifunction autonomous drone solutions integrating machine learning, predictive analytics, and advanced computing technologies, for government, defense, and industrial applications. This includes multifunctional drones for surveying, inspections, logistics, security, and defense applications. Its product portfolio under development includes the ZenaDrone 1000 for ISR defense and specialized cargo, the IQ Nano for indoor inventory management and security, the IQ Square for outdoor inspections and maintenance, the IQ Quad for land surveying, the IQ Aqua, for underwater applications, and the IQ Octo for precision agriculture. ZenaDrone operates three global manufacturing facilities in Arizona, Dubai, and Taiwan, and is advancing counter-UAS maritime interceptor drones and an integrated defense system.

Contacts for more information:

Company, Investors and Media:
Linda Montgomery
ZenaTech
312-241-1415

Investors:
Michael Mason
CORE IR
investors@zenatech.com

Safe Harbor

This press release and related comments by management of ZenaTech, Inc. include “forward-looking statements” within the meaning of U.S. federal securities laws and applicable Canadian securities laws. These forward-looking statements are subject to the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. This forward-looking information relates to future events or future performance of ZenaTech and reflects management’s expectations and projections regarding ZenaTech’s growth, results of operations, performance, and business prospects and opportunities, including statements about the development, features, availability, pricing, commercialization and market adoption of ZenaAI. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. In some cases, forward-looking information can be identified by terminology such as “may”, “will”, “should”, “expect”, “plan”, “anticipate”, “aim”, “seek”, “is/are likely to”, “believe”, “estimate”, “predict”, “potential”, “continue” or the negative of these terms or other comparable terminology intended to identify forward-looking statements. Forward-looking information in this document includes, but is not limited to ZenaTech’s expectations regarding its revenue, expenses, production, operations, costs, cash flows, and future growth; ZenaTech’s ability to deliver products to the market as currently contemplated, including software platforms such as ZenaAI; ZenaTech’s anticipated cash needs and its needs for additional financing; ZenaTech’s intention to grow the business and its operations and execution risk; the volatility of stock prices and market conditions in the industries in which ZenaTech operates; risks related to the development, testing, accuracy and performance of artificial intelligence and machine learning models; regulatory risks, including regulations governing drone operations; product development, validation and data quality and accuracy risks; customer adoption and recurring revenue opportunities; the competitive conditions of the industry; the ability to complete any contemplated acquisitions; market uncertainty; and applicable laws, regulations, and any amendments affecting the business of ZenaTech. Readers should not place undue reliance on forward-looking statements, which speak only as of the date of this release, and ZenaTech undertakes no obligation to update them except as required by law.

Vancouver, British Columbia, Oct. 22, 2026 (GLOBE NEWSWIRE) — NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce additional gold-antimony assays from the 2026 drill program at its Limousine Butte Project (the “Project”, “Limo Butte”) in Nevada. These results have extended mineralization by over 100 meters to the east of the Resurrection Ridge resource, adding significant mineralization potential both inside and outside of the 2026 Mineral Resource Estimate (“MRE”) pit-shell released on July 15, 2026 (see News Release).

NevGold CEO, Brandon Bonifacio, comments: “We are extremely pleased with the progress in the 2026 drill program. This latest set of drill results continues to demonstrate the significant oxide gold-antimony potential at Limo Butte, extending mineralization by over 100 meters to the east, both inside and outside of the Resurrection Ridge MRE pit-shell. We are also consistently encountering grades above our current MRE grade profile, which will be important as we advance the current drill program and future resource updates. The mineralized system remains open, and our geological model continues to successfully identify and expand gold-antimony mineralization across the Project. With approximately 50 holes and 12,000 metres completed to date, and 38 holes still pending assays, we believe there is significant potential for additional growth.” 

Bonifacio continues: “Importantly, with over $43 million in treasury, we have the financial flexibility to continue executing our growth strategy. The Preliminary Economic Assessment (“PEA”) is advancing on schedule, with targeted completion in Q1-2027. We intend to drive shareholder value through continued operational execution and project de-risking, which creates a compelling opportunity for existing and new investors on one of the most significant oxide gold-antimony projects in the United States.”

Key Highlights

• High-grade oxide gold-antimony mineralization extended eastward over 100 meters both inside and outside of 2026 MRE pit-shell:

• • LB26-011 (expansion inside and outside of 2026 pit-shell): 7.27 g/t AuEq over 3.0 meters (6.18 g/t Au, 0.28% Sb) within 1.55 g/t AuEq over 32.0 meters (0.92 g/t Au, 0.16% Sb)
  • LB26-008 (expansion inside and outside of 2026 pit-shell): 8.04 g/t AuEq over 3.0 meters (0.36 g/t Au, 1.98% Sb) within 0.42% Sb over 42.7 meters
  • LB26-015 (expansion inside of 2026 pit-shell): 2.35 AuEq over 7.6 meters (0.15 g/t Au, 0.57% Sb) and 0.73 AuEq over 67.1 meters (0.26 g/t Au, 0.12% Sb), both within 0.65 AuEq over 132.6 meters (0.18 g/t Au, 0.12% Sb)

• +$43 million in treasury focused on project development and growth strategy execution

• 50 holes completed, 38 holes with assays pending after this News Release

• Advancing Preliminary Economic Assessment (“PEA”) Engineering Study at Limo Butte with targeted completion Q1-2027

Limo Butte Planned 2026-2027 Activities / Status Update

NevGold will continue its active work programs at Limo Butte including:

• Continuing to drill test gold-antimony targets (~20,000 meters is planned in 2026 focused on the Bullet Zone / Armory Fault discoveries and resource conversion);

• Advancing metallurgical testwork (ongoing);

• Advancing PEA Engineering Study (in process, targeted completion Q1-2027);

• Commencing early permitting for future operations (in process; key driver of permitting is advancement of Engineering Study)

Figure 1 – Resurrection Ridge resource area with completed 2026 drilling. Figure includes outline of 2026 AuEq. resource pit-shell, priority expansion area for ongoing 2026 drilling, and intercepts for completed 2026 drilling. Ongoing road and pad construction efforts are also shown, highlighting focused efforts to expand Au and Sb mineralization to the east under the dolomite thrust. To view image please click here

Figure 2 – Section with Au values from 2026 MRE block model and Au intercepts from all drilling along section completed by NevGold in 2025-2026 drill programs. The drillholes in the 2026 drill program have expanded oxide mineralization both inside and outside of the recently announced 2026 MRE pit-shell.
To view image please click here

2026 Drilling Results – Resurrection Ridge

Hole ID	Length, m*	g/t Au***	% Sb***	g/t AuEq**	From, m	To, m
LB26-008 Upper	65.5	–	0.30%	–	4.6	70.1
including	42.7	–	0.42%	–	24.4	67.1
also including	3.0	0.36	1.98%	8.04	27.4	30.5
LB26-008 Lower	50.3	0.16	–	0.16	207.3	259.1
including	3.0	1.29	–	1.29	254.4	257.6
LB26-010	21.3	0.21	0.14%	0.75	56.4	77.7
including	9.1	0.30	0.15%	0.88	56.4	65.5
also including	4.6	–	0.28%	–	45.7	50.3
LB26-011	53.3	0.60	0.12%	1.06	56.4	111.3
including	32.0	0.92	0.16%	1.55	56.4	88.4
also including	3.0	6.18	0.28%	7.27	56.4	59.4
LB26-013	25.9	0.11	0.07%	0.37	13.7	39.6
including	4.6	0.30	0.07%	0.57	33.5	38.1
LB26-015	132.6	0.18	0.12%	0.65	0.00	132.6
including	67.1	0.26	0.12%	0.73	65.5	132.6
also including	7.6	0.15	0.57%	2.35	24.4	32.0

*Downhole thickness reported; true width varies depending on drill hole dip and is approximately 70% to 90% of downhole thickness.
**The gold equivalents (“AuEq”) are based on assumed metals prices of US$3,000/oz of gold and US$40,000 per tonne of antimony, and assumed metals recoveries of 80% for gold and 75% for antimony.
***Values less than 0.10 g/t Au and 0.05% Sb not included.

Drillhole Orientation Details

Hole ID	Target Zone	Easting	Northing	Elevation (m)	Length (m)	Azimuth	Dip
LB26-008	RR	667173	4417250	2189	305	160	-60
LB26-010	RR	667373	4417338	2232	81	90	-60
LB26-011	RR	667372	4417337	2232	214	105	-60
LB26-013	RR	667371	4417336	2232	214	240	-60
LB26-015	RR	667331	4417291	2238	133	200	-60

 
 

 

Figure 3 – Limousine Butte Land Holdings and District Exploration Activity To view image please click here

ON BEHALF OF THE BOARD

“Signed”
Brandon Bonifacio, President & CEO 

For further information, please contact Brandon Bonifacio at bbonifacio@nev-gold.com, call 604-337-4997, or visit our website at www.nev-gold.com.

Sampling Methodology, Quality Control and Quality Assurance
NevGold QA/QC protocols are followed on the Project and include insertion of duplicate, blank and standard samples in all drill holes. A 30g gold fire assay and multi-elemental analysis ICP-OES method was completed by ISO 17025 certified American Assay Labs, Reno.

Technical information contained in this news release has been reviewed and approved by Greg French, CPG, the Company’s Vice President, Exploration, who is NevGold’s Qualified Person (“QP”) under National Instrument 43-101 and responsible for technical matters of this release.

About the Company
NevGold is dedicated to discovering, de-risking, and rapidly advancing gold and critical metals projects across premier jurisdictions in Nevada and Idaho to drive shareholder value and strengthen US mineral security. The Company holds a 100% interest in the Limousine Butte (gold-antimony) and Cedar Wash (gold) projects in Nevada, and the Nutmeg Mountain (gold) and Zeus (copper) projects in Idaho. For more information, please visit www.nev-gold.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward Looking Statements

This news release contains forward-looking statements that are based on the Company’s current expectations and estimates. Forward-looking statements are frequently characterized by words such as “plan”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “suggest”, “indicate” and other similar words or statements that certain events or conditions “may” or “will” occur. Forward-looking statements include, but are not limited to, the proposed work programs at Limousine Butte, the exploration potential at Limousine Butte, the expansion of the  recently announced MRE at Limo Butte, and future potential project milestones such as the Preliminary Economic Assessment (“PEA”). Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual events or results to differ materially from estimated or anticipated events or results implied or expressed in such forward-looking statements. Such risks include, but are not limited to, general economic, market and business conditions, and the ability to obtain all necessary regulatory approvals. There is some risk that the forward-looking statements will not prove to be accurate, that the management’s assumptions may not be correct or that actual results may differ materially from such forward-looking statements. Accordingly, readers should not place undue reliance on the forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise. Forward-looking statements are not guarantees of future performance and accordingly undue reliance should not be put on such statements due to the inherent uncertainty therein.

SANTA CLARA, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) — Applied Materials, Inc. today announced that it will hold its fourth quarter and fiscal 2026 earnings conference call on Thursday, Nov. 12, 2026, at 4:30 p.m. ET / 1:30 p.m. PT.

The call will be webcast live at: https://ir.appliedmaterials.com. A replay will be available on the same day by 8:00 p.m. ET / 5:00 p.m. PT.

About Applied Materials
Applied Materials, Inc. (Nasdaq: AMAT) is the leader in materials engineering solutions that are at the foundation of virtually every new semiconductor and advanced display in the world. The technology we create is essential to advancing AI and accelerating the commercialization of next-generation chips. At Applied, we push the boundaries of science and engineering to deliver material innovation that changes the world. Learn more at www.appliedmaterials.com.

Contact:
Ricky Gradwohl (editorial/media) 408.235.4676
Mike Sullivan (financial community) 408.986.7977

Healthcare compliance expert brings more than 25 years of experience in corporate governance, investigations and fraud and abuse matters

WASHINGTON, Oct. 22, 2026 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Katie Norris as a Senior Managing Director in the Healthcare Risk Management & Advisory practice within the firm’s Forensic and Litigation Consulting segment.

Ms. Norris, who is based in Washington, D.C., has more than 25 years of experience in corporate governance and compliance, specializing in the pharmaceutical, biotechnology, medical device and healthcare industries. She advises chief compliance officers, legal counsel, senior executives and corporate boards on compliance program development, implementation, management, and oversight. Her expertise includes fraud and abuse compliance audits and investigations, compliance program effectiveness evaluations, and risk assessment and mitigation.

Ms. Norris has led internal investigations and supported life sciences and healthcare companies in investigations initiated by government agencies, including the U.S. Department of Justice, the U.S. Department of Health and Human Services Office of Inspector General, the U.S. Food and Drug Administration, the Centers for Medicare & Medicaid Services, the U.S. Securities and Exchange Commission and the Federal Trade Commission. She also has served as the lead expert for Independent Review Organization monitorships and as an expert witness in complex federal and state litigation involving healthcare compliance, corporate investigations, compliance operations, and healthcare fraud and abuse risk management.

In her role at FTI Consulting, Ms. Norris will advise clients on complex risk and compliance challenges, including investigations, audits and risk assessments involving potential healthcare fraud, waste, and abuse. She also will serve as an expert witness in healthcare fraud and abuse litigation, including whistleblower actions brought under the False Claims Act and private litigation.

“Life sciences companies are navigating rapid scientific and technological advances alongside increasing pricing pressures, patient access challenges and regulatory scrutiny,” said Wayne Gibson, Leader of FTI Consulting’s Healthcare Risk Management & Advisory practice. “Katie’s extensive experience in compliance, investigations, corporate governance and fraud and abuse matters will strengthen our ability to meet clients’ evolving needs. Working with our deep bench of experts across FTI Consulting, she will help clients manage risk, respond to complex matters and build effective, sustainable compliance programs.”

Prior to joining FTI Consulting, Ms. Norris was a senior managing director at Ankura, where she led the Life Sciences segment within the firm’s Healthcare & Life Sciences Disputes and Economics practice. Prior to that, she was a managing director at Epsilon Life Sciences. She has also held governance, risk and compliance roles at Guidehouse and Berkeley Research Group, LLC, and compliance officer roles at pharmaceutical and medical technology companies.

Commenting on her appointment, Ms. Norris said, “Life sciences and healthcare organizations need practical guidance that reflects the complexity of today’s regulatory, enforcement and business environment. FTI Consulting’s breadth of expertise provides a powerful platform for helping these organizations navigate complex matters, strengthen their compliance programs and make informed decisions. I look forward to working with my colleagues across the firm to support our clients as they address their critical risk management priorities, and the inherent challenges of regulatory and enforcement scrutiny.”

About FTI Consulting
FTI Consulting, Inc. is a leading global expert firm for organizations facing crisis and transformation, with more than 8,100 employees located in 32 countries and territories as of June 30, 2026. In certain jurisdictions, FTI Consulting’s services are provided through distinct legal entities that are separately capitalized and independently managed. The Company generated $3.8 billion in revenues during fiscal year 2025. More information can be found at www.fticonsulting.com.

FTI Consulting, Inc.
555 12^th Street NW
Washington, DC 20004
+1.202.312.9100

Investor Contact:
Mollie Hawkes
+1.617.747.1791
mollie.hawkes@fticonsulting.com

Media Contact:
Nick Emmons
+1.617.510.1676
nick.emmons@fticonsulting.com

VANCOUVER, British Columbia, Oct. 22, 2026 (GLOBE NEWSWIRE) — Brixton Metals Corporation (TSX-V: BBB, OTCQX: BBBXF) (the “Company” or “Brixton”) announces that, further to its news release dated September 23, 2026, the TSX Venture Exchange (the “TSXV”) has approved for filing the Company’s option agreement (the “Option Agreement”) with McKnight Resources AB (“McKnight”), an arm’s length party, pursuant to which McKnight has granted to Brixton the sole, exclusive and irrevocable right and option (the “Option”) to acquire an undivided 100% interest in and to certain mineral exploration permits located in Hällefors Municipality, Örebro County, south central Sweden, commonly known by the names “Silvergruvan 100” and “Silvergruvan 200” (collectively, the “Silvergruvan Property”). No finder’s fees are payable in connection with the Option.

The Silvergruvan Property comprises 1,460 hectares and is prospective for silver, gold, lead, zinc, antimony and indium. The Silvergruvan Property saw historical mining activity spanning from the 1600s to the late 20^th century and sits on the western margin of the Bergslagen province, placing the property in immediate proximity to major active polymetallic operations. Silvergruvan shares similar geology to major silver-lead-zinc deposits like Garpenberg⁽¹⁾, Sala, Zinkgruvan⁽¹⁾ in the region.

According to Boliden, in 2025, the most valuable commodity for Garpenberg was silver. Silver accounted for 47% of the revenue, followed by zinc 32%, gold at 11%, lead at 10% and copper at less than 1%.⁽²⁾

Transaction Highlights

Brixton may exercise the Option on completion of the following:

Date	Share Issuances(*)		Exploration Expenditures
On or before the 1st anniversary of the Option effective date(**)	$150,000		$300,000
On or before the 2nd anniversary of the Option effective date	$250,000		$1,000,000
On or before the 3rd anniversary of the Option effective date	$500,000		$2,000,000
Any time following completion of the above Share issuances and exploration expenditures	$600,000
TOTAL	$1,500,000		$3,300,000

(*) Any common shares in the capital of the Company (the “Shares”) issued pursuant to the Option Agreement shall have an issue price, as and when issued, equal to the 20-day volume weighted average trading price of the Shares on a recognized stock exchange in Canada on which the Shares are then listed, such price being based on the 20 trading days preceding the date the Company elects to issue such Shares; provided, however, that the issue price shall not be less than $0.50 being the ‘Discounted Market Price’ of Shares on the TSXV as of September 23, 2026.
(**) The Option effective date being October 21, 2026.

Upon Brixton exercising the Option, it shall grant a 2.0% net smelter returns royalty (the “Royalty”) on the Silvergruvan Property in favour of McKnight, subject to a right at any time to reduce the Royalty to 1.0% by paying $1,500,000 or, subject to applicable approval of the recognized stock exchange on which the Shares are then listed, issuing Shares equal to $1,500,000, such Shares shall have an issue price, as and when issued, equal to the 20-day volume weighted average trading price of the Shares on a recognized stock exchange on which the Shares are then listed, such price being based on the 20 trading days preceding the date the Company elects to issue such Shares.

All Share issuances and exploration expenditures are at the discretion of Brixton. Brixton may make up any shortfall in exploration expenditures for a period by making a cash payment to McKnight before the end of such period. Brixton may also accelerate the Option by making any Share issuances and exploration expenditures within a shorter period of time. Brixton shall act as operator during the Option period.

All Shares issued pursuant to the Option Agreement will be subject to a hold period of four months and one day from the date of issuance in accordance with applicable Canadian securities laws. In addition, each tranche of Share issuance under the Option Agreement will be subject to a voluntary lock-up subject to a release schedule of 25% on issuance, 25% four months from the date of issuance, 25% eight months from the date of issuance and 25% twelve months from the date of issuance.

Reference Sources and Links
⁽¹⁾ https://www.boliden.com/operations/mines/boliden-garpenberg/
⁽¹⁾ https://www.boliden.com/operations/mines/boliden-zinkgruvan/
⁽²⁾ Mineral Resources and Mineral Reserves Garpenberg 2025-12-31 (click link)

Qualified Person (QP)

Mr. Gary Thompson, P.Geo., is the Chairman and CEO and a senior geologist for the Company who is a ‘Qualified Person’ as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects. Mr. Thompson has reviewed and approved the technical information presented herein. The QP conducted a site visit on August 25, 2026 and considers Silvergruvan a property of merit and recommends further exploration. Further, the QP has not completed sufficient work on the historical data to confirm the accuracy of the information provided, and there is no certainty that further exploration will result in a mineral resource.

About Brixton Metals Corporation

Brixton Metals is a Canadian exploration company focused on advancing its mining projects. Brixton wholly owns five exploration projects: the Langis and Hudson Bay silver Projects in Ontario; the Thorn copper-gold-silver-molybdenum Project in NW British Columbia; the Hog Heaven copper-silver-gold Project in NW Montana, USA, which is optioned to Ivanhoe Electric Inc.; and the Atlin Goldfields Project in northwest BC. Brixton holds an option to acquire a 100% interest in the silver-focused Silvergruvan Project in Sweden. Brixton Metals Corporation shares trade on the TSX-V under the ticker symbol BBB, and on the OTCQX under the ticker symbol BBBXF. For more information about Brixton, please visit our website at www.brixtonmetals.com.

On Behalf of the Board of Directors

Mr. Gary R. Thompson, Chairman and CEO
info@brixtonmetals.com

For Investor Relations inquiries, please contact: Mr. Michael Rapsch, Vice President Investor Relations. email: michael.rapsch@brixtonmetals.com or call Tel: 604-630-9707.

Follow us on:
LinkedIn | Twitter/X | Facebook | Instagram

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

Information set forth in this news release may involve forward-looking information under applicable securities laws. Forward-looking information are statements and information that relate to future, not past, events. In this context, forward-looking information often addresses expected future business and financial performance, and often contains words such as “anticipate”, “believe”, “plan”, “estimate”, “expect”, and “intend”; information and statements that an action or event “may”, “might”, “could”, “should”, or “will” be taken or occur, or other similar expressions. All information other than information of historical fact included herein are forward-looking information, including, without limitation, information regarding the Company’s business plans and strategies of operations, the Silvergruvan Property and potential for exploration; and the Option. By its nature, forward-looking information involves known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information. Such factors include, among others, the following risks: the need for additional financing; operational risks associated with mineral exploration; fluctuations in commodity prices; title matters; and the additional risks identified in the annual information form of the Company or other reports and filings with the TSXV and applicable Canadian securities regulators. Forward-looking information is based on management’s beliefs, estimates and opinions on the date that such information is provided and the Company undertakes no obligation to update forward-looking information if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable securities laws. Investors are cautioned against attributing undue certainty to forward-looking information.

PALO ALTO, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today announced that it will release its third quarter 2026 financial results and business update after the market closes on Thursday, October 29, 2026. BridgeBio will host a conference call to discuss the financial results and program updates at 4:30 pm ET the same day.

To access the live webcast of BridgeBio’s presentation, please visit the “Events & Presentations” page within the Investors section of the BridgeBio website at investor.bridgebio.com/events-and-presentations/. A replay of the webcast will be available on the BridgeBio website for 30 days following the event.

Participants may access the webcast by registering online using the following link, here.

About BridgeBio Pharma, Inc.
BridgeBio exists to develop transformative medicines for genetic conditions. Millions of people worldwide living with genetic conditions lack treatment options, often because drug development for small patient populations can be commercially challenging. We aim to bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations. Our decentralized, hub-and-spoke model is designed for speed, precision, and scalability. Autonomous and empowered teams focus on individual conditions, while a central hub provides the clinical, regulatory, and commercial capabilities needed to bring innovation to market. For more information, visit bridgebio.com and follow us on LinkedIn, X, Facebook, Instagram, YouTube, and TikTok.

BridgeBio Media Contact:
Kaitlyn Reilly, Director, Communications
contact@bridgebio.com
(650) 789-8220

BridgeBio Investor Contact:
BridgeBio Investor Relations
ir@bridgebio.com

NEWTON, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (Acumen), a clinical-stage biopharmaceutical company developing novel therapeutics that target soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), will present three key poster presentations at the upcoming 19^th Annual Clinical Trials on Alzheimer’s Disease (CTAD) conference taking place in Boston. The presentations focus on Acumen’s Phase 2 ALTITUDE-AD trial of sabirnetug (ACU193) for the treatment of early AD, including preliminary baseline characteristics of study participants, study participant and partner experience, and treatment expectations and motivations. The conference will be held November 16-19, 2026, both in-person and online.

“These presentations reflect Acumen’s commitment to understanding the biology of early AD as well as the full experience, including the perspectives of patients and care partners living with it every day,” said Eric Siemers, M.D., Chief Medical Officer of Acumen Pharmaceuticals. “These important insights from our study collaborators and participants in ALTITUDE-AD help keep their needs at the center of our efforts to advance sabirnetug as a potential treatment of choice for AD.”

Acumen’s presentation details are as follows:

Topic: P015 ALTITUDE-AD: Baseline characteristics of participants randomized in a phase 2 trial of sabirnetug in early Alzheimer’s disease

Date/Time: Monday, November 16, 2:00 p.m. – Tuesday, November 17, 5:30 p.m. EST
Format: Poster Presentation
Session: Poster Session 1
Presenting Author: Linda Pao, MD, Medical Director and Principal Investigator, JEM Research Institute

Topic: P023 ALTITUDE-AD: Qualitative interviews assessing treatment expectations and motivations for clinical trial participation in early Alzheimer’s disease

Date/Time: Monday, November 16, 2:00 p.m. – Tuesday, November 17, 5:30 p.m. EST
Format: Poster Presentation
Session: Poster Session 1
Presenting Author: Stephanie Cline, PhD, Health Outcomes Consultant, Acumen Pharmaceuticals

Topic: P024 Perspectives on the care experience in early Alzheimer’s: Narratives from study partners in the ALTITUDE-AD clinical trial

Date/Time: Monday, November 16, 2:00 p.m. – Tuesday, November 17, 5:30 p.m. EST
Format: Poster Presentation
Session: Poster Session 1
Presenting Author: Stephanie Cline, PhD, Health Outcomes Consultant, Acumen Pharmaceuticals

About Sabirnetug (ACU193)

Sabirnetug (ACU193) is a humanized monoclonal antibody (mAb) discovered and developed based on its selectivity for soluble amyloid beta oligomers (AβOs), which are a highly toxic and pathogenic form of Aβ, relative to Aβ monomers and amyloid plaques. Soluble AβOs have been observed to be potent neurotoxins that bind to neurons, inhibit synaptic function and induce neurodegeneration. By selectively targeting toxic soluble AβOs, sabirnetug aims to address the hypothesis that soluble AβOs are an early and persistent underlying cause of the neurodegenerative process in Alzheimer’s disease (AD). Sabirnetug has been granted Fast Track designation for the treatment of early AD by the U.S. Food and Drug Administration and is currently being evaluated in a Phase 2 study in patients with early AD.

About ALTITUDE-AD (Phase 2)

Initiated in 2024, ALTITUDE-AD is a Phase 2, multi-center, randomized, double-blind, placebo-controlled clinical trial designed to evaluate the efficacy and safety of sabirnetug (ACU193) infusions administered once every four weeks in slowing cognitive and functional decline as compared to placebo in participants with early Alzheimer’s disease. The study has enrolled 542 individuals with early Alzheimer’s disease (mild cognitive impairment or mild dementia due to AD) at multiple investigative sites located in the United States, Canada, the European Union and the United Kingdom. Topline results are expected in late 2026. More information can be found on www.clinicaltrials.gov, NCT identifier NCT06335173.

About Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals is a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD). Acumen’s scientific founders pioneered research on AβOs, which a growing body of evidence indicates are early and persistent triggers of Alzheimer’s disease pathology. Acumen is currently focused on advancing its investigational product candidate, sabirnetug (ACU193), a humanized monoclonal antibody that selectively targets toxic soluble AβOs, in its ongoing Phase 2 clinical trial ALTITUDE-AD (NCT06335173) in early symptomatic AD, following positive results in its Phase 1 trial INTERCEPT-AD. Acumen is investigating a subcutaneous formulation of sabirnetug using Halozyme’s proprietary ENHANZE^® drug delivery technology. Acumen is also collaborating with JCR Pharmaceuticals to develop an Enhanced Brain Delivery™ (EBD™)-enabled therapy for Alzheimer’s disease utilizing a transferrin-receptor-targeting blood-brain barrier-penetrating technology. The company is headquartered in Newton, Mass. For more information, visit www.acumenpharm.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Any statement describing Acumen’s goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement. Words such as “believes,” “expects,” “anticipates,” “could,” “should,” “would,” “seeks,” “aims,” “plans,” “potential,” “will,” “milestone” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements include statements concerning Acumen’s business and the therapeutic potential of Acumen’s product candidate, sabirnetug (ACU193).. These statements are based upon the current beliefs and expectations of Acumen management, and are subject to certain factors, risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing safe and effective human therapeutics. Such risks may be amplified by the impacts of geopolitical events and macroeconomic conditions, such as rising inflation and interest rates, supply disruptions and uncertainty of credit and financial markets. These and other risks concerning Acumen’s programs are described in additional detail in Acumen’s filings with the Securities and Exchange Commission (“SEC”), including in Acumen’s most recent Annual Report on Form 10-K, and in subsequent filings with the SEC. Copies of these and other documents are available from Acumen. Additional information will be made available in other filings that Acumen makes from time to time with the SEC. These forward-looking statements speak only as of the date hereof, and Acumen expressly disclaims any obligation to update or revise any forward-looking statement, except as otherwise required by law, whether, as a result of new information, future events or otherwise.

Investors:
Alex Braun
abraun@acumenpharm.com

Media:
ICR Healthcare
AcumenPR@icrhealthcare.com